Congratulations to Gabriel Funingana whose abstract ‘DNA-repair patterns and immune contexture define durable benefit for BRCA2-deficient high-grade serous carcinoma in a national genomic study’ was chosen for the ESMO Merit Award at the recent ESMO Congress 2025 in Berlin in October.
